Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
Honeywell announced a plan to spin off its Advanced Materials business into an independent, U.S. publicly traded company...
read more
Colorcon and specialty chemicals provider LOTTE Fine Chemical have inked a multi-year partnership to develop and manufacture pharmaceutical and dietary supplement formulations.
read more
The U.S. FDA says Trinity Gold, a dietary supplement promoted for joint and muscle pain, contains hidden drug ingredients.
read more
Two patented dietary supplement ingredients from Gateway Health Alliances increased GLP-1 levels, reduced body weight, and improved metabolic biomarkers in a 12-week clinical study.
read more
IRLAB Therapeutics has shared positive phase 1 data for its once daily oral tablet that the Swedish drugmaker hopes will become become the first treatment for apathy in neurological disorders.
read more
Pfizer has sold a substantial stake in consumer health care group Haleon, cutting its shareholding in the maker of Centrum vitamins and Advil painkillers from 22.6% to 15%...
read more
Roche's Genentech will acquire a portfolio of next-generation CDK inhibitors from Regor Pharmaceuticals for the treatment of breast cancer...
read more
The FDA has approved Cobenfy, introducing a fundamentally new approach to treating schizophrenia by selectively targeting M1 and M4 receptors in the brain without blocking D2 receptors...
read more
IntraBio's oral drug, Aqneursa, becomes the second therapy to get an FDA nod for the treatment of Niemann-Pick disease type C in the past week...
read more
Additions to sites in Cincinnati, Ohio and Bend, Oregon will broaden the company’s early development capabilities...
read more
Aenova, one of the world's leading CDMOs (Contract Development and Manufacturing Organizations) for the pharmaceutical and healthcare industries, is implementing a new gummy line at its site in Cornu, Romania.
read more
Ipsen announced that the European Commission has approved Kayfanda (odevixibat) under exceptional circumstances for the treatment of cholestatic pruritus in Alagille Syndrome (ALGS) in patients aged 6 months or older. Kayfanda is a once-daily non-systemic ileal bile acid transport (IBAT) inhibitor.
read more
The label expansion for Kisqali will double the population eligible for the CDK4/6 inhibitor adjuvant therapy
read more
The agency handed Vanda a CRL for what would have been the first effective treatment approved by the FDA for the stomach paralysis condition in over 40 years.
The U.S. FDA declined to approve Vanda Pharmaceuticals’ New Drug Application for tradipitant for the treatment of symptoms in gastroparesis, handing Vanda a complete response letter.
read more
Recipharm announced a significant investment in its Oral Solid Development and Pilot Scale Centre in Zwickau, Germany. The investment includes three new GMP Pilot Scale suites for blending, tableting and hard capsule filling, which will complement the existing GMP pilot scale capabilities in dry granulation and wet granulation and related tools for...
read more